info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Blood Screening Market Research Report By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) - Forecast till 2032


ID: MRFR/MED/5434-HCR | 85 Pages | Author: Rahul Gotadki| November 2024

Blood Screening Market Segmentation


Blood Screening Technology Outlook (USD Billion, 2019-2030)




  • Nucleic Acid Amplification Test




  • Enzyme-Linked Immunosorbent Assay




  • Next-Generation Sequencing




Blood Screening End User Outlook (USD Billion, 2019-2030)




  • Hospitals




  • Clinics




  • Others




Blood Screening Product & Services Outlook (USD Billion, 2019-2030)




  • Reagents




  • Instrument




Blood Screening Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • North America Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • North America Blood Screening by Product & Services




      • Reagents




      • Instrument






    • US Outlook (USD Billion, 2019-2030)




    • US Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • US Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • US Blood Screening by Product & Services




      • Reagents




      • Instrument






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • CANADA Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • CANADA Blood Screening by Product & Services




      • Reagents




      • Instrument








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Europe Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Europe Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Germany Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Germany Blood Screening by Product & Services




      • Reagents




      • Instrument






    • France Outlook (USD Billion, 2019-2030)




    • France Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • France Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • France Blood Screening by Product & Services




      • Reagents




      • Instrument






    • UK Outlook (USD Billion, 2019-2030)




    • UK Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • UK Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • UK Blood Screening by Product & Services




      • Reagents




      • Instrument






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • ITALY Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • ITALY Blood Screening by Product & Services




      • Reagents




      • Instrument






    • SPAIN Outlook (USD Billion, 2019-2030)




    • Spain Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Spain Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Spain Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Rest Of Europe Outlook (USD Billion, 2019-2030)




    • Rest Of Europe Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • REST OF EUROPE Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • REST OF EUROPE Blood Screening by Product & Services




      • Reagents




      • Instrument








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Asia-Pacific Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Asia-Pacific Blood Screening by Product & Services




      • Reagents




      • Instrument






    • China Outlook (USD Billion, 2019-2030)




    • China Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • China Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • China Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Japan Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Japan Blood Screening by Product & Services




      • Reagents




      • Instrument






    • India Outlook (USD Billion, 2019-2030)




    • India Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • India Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • India Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Australia Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Australia Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Rest of Asia-Pacific Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Rest of Asia-Pacific Blood Screening by Product & Services




      • Reagents




      • Instrument








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Rest of the World Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Rest of the World Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Middle East Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Middle East Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Africa Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Africa Blood Screening by Product & Services




      • Reagents




      • Instrument






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America Blood Screening by Technology




      • Nucleic Acid Amplification Test




      • Enzyme-Linked Immunosorbent Assay




      • Next-Generation Sequencing






    • Latin America Blood Screening by End User




      • Hospitals




      • Clinics




      • Others






    • Latin America Blood Screening by Product & Services




      • Reagents




      • Instrument








 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Blood Screening Market, by Technology

6.1 Introduction

6.2 Nucleic Acid Amplification Test (NAT)

6.2.1 Transcription-Mediated Amplification (TMA)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.2.2 Real-Time Polymerase Chain Reaction (PCR)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3 Enzyme-Linked Immunosorbent Assay (ELISA)

6.3.1 ELISA Market, By Platform

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.3.2 ELISA Market, By Generation

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.4 Rapid Tests

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.5 Next-Generation Sequencing (NGS)

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

6.6 Western Blotting

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 7. Global Blood Screening Market, by Product and Services

7.1 Introduction

7.2 Reagent and kits

7.2.1 NAT Reagents & Kits

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.2.2 ELISA Reagents & Kits

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3 Enzymes and Polymerases

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4 Standards and Controls

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.5 Probes and Primers

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.6 Buffers, Nucleotides, and Solutions

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.7 Immunosorbents

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.8 Controls

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.9 Instruments

7.3.1 Rental Purchase

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.3.2 Outright Purchase

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

7.4 Software and services

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 8. Global Blood Screening Market, By End User

8.1 Hospitals

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.2 Clinics

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.3 Research Institutes and Academic Center

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.4 Blood Banks

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

8.5 Others

Market Estimates & Forecast, by Region, 2023-2030

Market Estimates & Forecast, by Country, 2023-2030

Chapter 9. Global Blood Screening Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Grifols

11.1.1 Company Overview

11.1.2 Product and Services Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 F. Hoffmann-La Roche

11.2.1 Company Overview

11.2.2 Product and Services Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Abbott Laboratories

11.3.1 Company Overview

11.3.2 Product and Services Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Biomérieux

11.4.1 Company Overview

11.4.2 Product and Services Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Bio-Rad Laboratories, Inc.

11.5.1 Company Overview

11.5.2 Product and Services Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Siemens Healthineers (A Subsidiary of Siemens AG)

11.6.1 Company Overview

11.6.2 Product and Services Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Ortho Clinical Diagnostics, Inc.

11.7.1 Overview

11.7.2 Product and Services Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Thermo Fisher Scientific, Inc.

11.8.1 Overview

11.8.2 Product and Services Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Beckman Coulter (A Subsidiary of Danaher Corporation)

11.9.1 Overview

11.9.2 Product and Services Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Becton, Dickinson and Company

11.10.1 Overview

11.10.2 Product and Services Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Blood Screening Market Industry

Chapter 13. Appendix

LIST OF TABLES:

Table 1 Global Blood Screening Market Synopsis, 2023-2030

Table 2 Global Blood Screening Market Estimates and Forecast, 2023-2030 (USD Million)

Table 3 Global Blood Screening Market, by Region, 2023-2030 (USD Million)

Table 4 Global Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 5 Global Blood Screening, by Product and Services, 2023-2030 (USD Million)

Table 6 Global Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 7 North America: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 8 North America: Blood Screening, by Product and Services, 2023-2030 (USD Million)

Table 9 North America: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 10 US: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 11 US: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 12 US: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 13 Canada: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 14 Canada: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 15 Canada: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 16 South America: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 17 South America: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 18 South America: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 19 Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 20 Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 21 Europe: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 22 Western Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 23 Western Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 24 Western Europe: Blood Screening Market, by End User, 2023-2030(USD Million)

Table 25 Eastern Europe: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 26 Eastern Europe: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 27 Eastern Europe: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 28 Asia-Pacific: Blood Screening Market, by Technology, 2023-2030 (USD Million)

Table 29 Asia-Pacific: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 30 Asia-Pacific: Blood Screening Market, by End User, 2023-2030 (USD Million)

Table 31 Middle East & Africa: Blood Screening by Market, by Technology, 2023-2030 (USD Million)

Table 32 Middle East & Africa: Blood Screening Market, by Product and Services, 2023-2030 (USD Million)

Table 33 Middle East & Africa Blood Screening Market, by End User, 2023-2030 (USD Million)

LIST OF FIGURES:

Figure 1 Research Process

Figure 2 Market Structure for Global Blood Screening Market

Figure 3 Market Dynamics for Global Blood Screening Market

Figure 4 Global Blood Screening Market Share, by Technology, 2023

Figure 5 Global Blood Screening Market Share, by Product and Services, 2023

Figure 6 Global Blood Screening Market Share, by End User, 2023

Figure 7 Global Blood Screening Market Share, by Region, 2023

Figure 8 North America: Blood Screening Market Share, by Country, 2023

Figure 9 Europe: Blood Screening Market Share, by Country, 2023

Figure 10 Asia-Pacific: Blood Screening Market Share, by Country, 2023

Figure 11 Middle East & Africa: Blood Screening Market Share, by Country, 2023

Figure 12 Global Blood Screening Market: Company Share Analysis, 2023 (%)

Figure 13 Grifols: Key Financials

Figure 14 Grifols: Segmental Revenue

Figure 15 Grifols: Geographical Revenue

Figure 16F. Hoffmann-La Roche: Key Financials

Figure 17F. Hoffmann-La Roche: Segmental Revenue

Figure 18F. Hoffmann-La Roche: Geographical Revenue

Figure 19Abbott Laboratories: Key Financials

Figure 20Abbott Laboratories: Segmental Revenue

Figure 21Abbott Laboratories: Geographical Revenue

Figure 22Biomérieux: Key Financials

Figure 23Biomérieux: Segmental Revenue

Figure 24Biomérieux: Geographical Revenue

Figure 25Bio-Rad Laboratories, Inc.: Key Financials

Figure 26Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 27Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 28Siemens Healthineers (A Subsidiary of Siemens AG): Key Financials

Figure 29Siemens Healthineers (A Subsidiary of Siemens AG): Segmental Revenue

Figure 30 Siemens Healthineers (A Subsidiary of Siemens AG): Geographical Revenue

Figure 31Ortho Clinical Diagnostics, Inc.: Key Financials

Figure 32Ortho Clinical Diagnostics, Inc.: Segmental Revenue

Figure 33Ortho Clinical Diagnostics, Inc.: Geographical Revenue

Figure 34Thermo Fisher Scientific, Inc.: Key Financials

Figure 35Thermo Fisher Scientific, Inc.: Segmental Revenue

Figure 36Thermo Fisher Scientific, Inc.: Geographical Revenue

Figure 37Beckman Coulter (A Subsidiary of Danaher Corporation): Key Financials

Figure 38 Beckman Coulter (A Subsidiary of Danaher Corporation): Segmental Revenue

Figure 39 Beckman Coulter (A Subsidiary of Danaher Corporation): Geographical Revenue

Figure 40Becton, Dickinson and Company: Key Financials

Figure 41Becton, Dickinson and Company: Segmental Revenue

Figure 42Becton, Dickinson and Company: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.